MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to rani...
-$29,673K
(1.15%↑ Y/Y)
Net loss
attributable to...
-$11,277K
(57.55%↑ Y/Y)
Net loss
-$40,950K
(27.63%↑ Y/Y)
Interest income and
other, net
$827K
(-53.09%↓ Y/Y)
Loss from operations
-$38,310K
(28.14%↑ Y/Y)
Interest expense and
other, net
$2,891K
(-42.56%↓ Y/Y)
Contract revenue
$1,633K
(58.85%↑ Y/Y)
Loss on
extinguishment of debt
-$576K
Total operating
expenses
$39,943K
(-26.50%↓ Y/Y)
Research and development
$20,205K
(-24.27%↓ Y/Y)
General and
administrative
$19,738K
(-17.57%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. (RANI)